Pfizer Inc. v. Teva Pharmaceuticals USA Inc.

Case Number: CLB0180

Date: 03.07.2008

Citation: 86 U.S.P.Q.2d 1001 (Fed. Cir. 2008)

Claims in a continuation-in-part application filed after a restriction requirement in a parent application can be found invalid based on obviousness-type double patenting in view of the parent application.

Download PDF Return to Case Law Briefs Main Page